首页 > 最新文献

Surgical Practice最新文献

英文 中文
C-reactive protein as an early predictor of anastomotic dehiscence in various types of reconstruction in elective abdominal surgery C反应蛋白作为择期腹部手术中各种类型重建吻合口破裂的早期预测因子
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-07-25 DOI: 10.1111/1744-1633.12646
Milena Scepanovic, Tomislav Randjelovic, Aleksandar Karamarkovic, Vladimir Cuk, Goran Stanojevic, Bojan Kovacevic

Objective

The most important factor in abdominal surgery is the successful healing of the intestinal anastomosis performed. This study aims to evaluate the role of C-reactive protein (CRP) in predicting anastomotic dehiscence in the first week following surgery.

Methods

The study included 100 patients surgically treated over a period of 1 year. Postoperative (p/o) values of CRP, leukocyte (white blood cells [WBCs]) and body temperature (BT) were measured in relation to the development of p/o complications.

Results

CRP p/o values were significantly higher in patients with complications and proved helpful in predicting p/o complications, while WBC and BT were not. For the development of anastomotic leakage, receiver operating characteristic curve shows the earliest diagnostic accuracy on the third p/o day with the cut-off value of 115.1 mg/L; however, the largest area under the curve was on the fifth p/o day with a cut-off value of 59.2 mg/L, a sensitivity of 89%, a specificity of 61%, a positive predictive value (PPV) of 21.9 and a negative predictive value (NPV) of 100.

Conclusions

Measurement of p/o CRP values may indicate problematic healing of digestive tract anastomosis before the appearance of clinical signs. High sensitivity and high NPV allow us to rule out p/o complications and anastomotic dehiscence with great certainty and safely discharge these patients from the hospital.

目的腹部外科手术中最重要的因素是肠吻合术的成功愈合。本研究旨在评估c反应蛋白(CRP)在术后第一周预测吻合口裂开的作用。方法对100例手术治疗1年的患者进行研究。测定术后CRP、白细胞(白细胞[wbc])、体温(BT)与p/o并发症发生的关系。结果CRP p/o值在并发症患者中显著升高,有助于预测p/o并发症,而WBC和BT则无此作用。对于吻合口漏的发展,患者工作特征曲线显示第3 p/o天诊断准确率最早,临界值为115.1 mg/L;曲线下面积最大的是第5 p/o天,临界值为59.2 mg/L,敏感性为89%,特异性为61%,阳性预测值为21.9,阴性预测值为100。结论p/o CRP可在临床症状出现前提示消化道吻合口愈合问题。高灵敏度和高NPV使我们能够非常确定地排除p/o并发症和吻合口裂开,并安全出院。
{"title":"C-reactive protein as an early predictor of anastomotic dehiscence in various types of reconstruction in elective abdominal surgery","authors":"Milena Scepanovic,&nbsp;Tomislav Randjelovic,&nbsp;Aleksandar Karamarkovic,&nbsp;Vladimir Cuk,&nbsp;Goran Stanojevic,&nbsp;Bojan Kovacevic","doi":"10.1111/1744-1633.12646","DOIUrl":"10.1111/1744-1633.12646","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The most important factor in abdominal surgery is the successful healing of the intestinal anastomosis performed. This study aims to evaluate the role of C-reactive protein (CRP) in predicting anastomotic dehiscence in the first week following surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study included 100 patients surgically treated over a period of 1 year. Postoperative (p/o) values of CRP, leukocyte (white blood cells [WBCs]) and body temperature (BT) were measured in relation to the development of p/o complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>CRP p/o values were significantly higher in patients with complications and proved helpful in predicting p/o complications, while WBC and BT were not. For the development of anastomotic leakage, receiver operating characteristic curve shows the earliest diagnostic accuracy on the third p/o day with the cut-off value of 115.1 mg/L; however, the largest area under the curve was on the fifth p/o day with a cut-off value of 59.2 mg/L, a sensitivity of 89%, a specificity of 61%, a positive predictive value (PPV) of 21.9 and a negative predictive value (NPV) of 100.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Measurement of p/o CRP values may indicate problematic healing of digestive tract anastomosis before the appearance of clinical signs. High sensitivity and high NPV allow us to rule out p/o complications and anastomotic dehiscence with great certainty and safely discharge these patients from the hospital.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 4","pages":"205-215"},"PeriodicalIF":0.8,"publicationDate":"2023-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76305102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gasless laparoscopy versus conventional laparoscopy and laparotomy: A systematic review on the safety and efficiency 无气腹腔镜与传统腹腔镜和剖腹手术的安全性和有效性的系统评价
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-06-13 DOI: 10.1111/1744-1633.12643
Haitham Shoman PhD, Simone Sandler MPH, Alexander Peters MPH, Ameer Farooq, Magdalena Gruendl, Shauna Trinh, James Little, Alex Woods, William Bolton, Abubakar Abioye, David Ljungman

Background

Gasless laparoscopy (GL) emerged to overcome the clinical and financial challenges of pneumoperitoneum and is often seen as a viable option for use in resource-limited settings as a means of saving costs and resources. This study aims to systematically review the evidence available on the safety and efficiency of GL compared with conventional laparoscopy (CL) and laparotomy.

Methods

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, Medline, Embase, Web of Science and Cochrane databases were searched. Variables of interest were determined a priori and Covidence software was used to screen studies for inclusion without demographic preference. The quality of studies was assessed using the Cochrane Risk Assessment tool.

Results

Of the 1080 studies screened, a total of 43 studies were included. Laparoscopic cholecystectomy was by far the most studied intervention in randomised studies. In these, the mean setup time for gasless and CL was 13.14 (95% CI −0.16 to 26.44) and 12.8 (95% CI −10.86 to 36.47) minutes, respectively. The mean duration of surgery for gasless and CL was 89.39 (95% CI 77.44 to 101.34) and 72.59 (95% CI 63.44 to 81.74) minutes, respectively, and the mean length of stay was 4.25 (95% CI 2.02 to 6.48) and 4.04 (95% CI 1.72 to 6.36) days, respectively. Most reported complications were haemorrhage and infection with no assessable statistical difference.

Conclusions

Although GL seems to be a feasible approach for many general surgery interventions, the observed outcomes based on safety and efficiency are not sufficient to recommend GL as an alternative to CL or laparotomy. Larger randomised trials with a low risk of bias are warranted.

背景无气腹腔镜(GL)是为了克服气腹的临床和财务挑战而出现的,通常被视为在资源有限的环境中使用的一种可行的选择,以节省成本和资源。本研究旨在系统地回顾GL与传统腹腔镜(CL)和剖腹手术相比的安全性和有效性的现有证据。方法按照系统评价和荟萃分析首选报告项目(PRISMA)指南,检索Medline、Embase、Web of Science和Cochrane数据库。感兴趣的变量是先验确定的,Covidence软件用于筛选没有人口统计学偏好的纳入研究。使用Cochrane风险评估工具对研究质量进行评估。结果在筛选的1080项研究中,共纳入43项研究。腹腔镜胆囊切除术是迄今为止随机研究中研究最多的干预措施。其中,无气和CL的平均设置时间分别为13.14分钟(95%CI−0.16至26.44)和12.8分钟(95%CI−10.86至36.47)。无气和CL的平均手术时间分别为89.39(95%CI 77.44至101.34)和72.59(95%CI 63.44至81.74)分钟,平均住院时间分别为4.25(95%CI 2.02至6.48)和4.04(95%CI 1.72至6.36)天。大多数报告的并发症是出血和感染,没有可评估的统计差异。结论尽管GL似乎是许多普通外科干预措施的可行方法,但基于安全性和有效性的观察结果不足以推荐GL作为CL或剖腹手术的替代方案。有必要进行较低偏倚风险的大型随机试验。
{"title":"Gasless laparoscopy versus conventional laparoscopy and laparotomy: A systematic review on the safety and efficiency","authors":"Haitham Shoman PhD,&nbsp;Simone Sandler MPH,&nbsp;Alexander Peters MPH,&nbsp;Ameer Farooq,&nbsp;Magdalena Gruendl,&nbsp;Shauna Trinh,&nbsp;James Little,&nbsp;Alex Woods,&nbsp;William Bolton,&nbsp;Abubakar Abioye,&nbsp;David Ljungman","doi":"10.1111/1744-1633.12643","DOIUrl":"https://doi.org/10.1111/1744-1633.12643","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Gasless laparoscopy (GL) emerged to overcome the clinical and financial challenges of pneumoperitoneum and is often seen as a viable option for use in resource-limited settings as a means of saving costs and resources. This study aims to systematically review the evidence available on the safety and efficiency of GL compared with conventional laparoscopy (CL) and laparotomy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, Medline, Embase, Web of Science and Cochrane databases were searched. Variables of interest were determined <i>a priori</i> and Covidence software was used to screen studies for inclusion without demographic preference. The quality of studies was assessed using the Cochrane Risk Assessment tool.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 1080 studies screened, a total of 43 studies were included. Laparoscopic cholecystectomy was by far the most studied intervention in randomised studies. In these, the mean setup time for gasless and CL was 13.14 (95% CI −0.16 to 26.44) and 12.8 (95% CI −10.86 to 36.47) minutes, respectively. The mean duration of surgery for gasless and CL was 89.39 (95% CI 77.44 to 101.34) and 72.59 (95% CI 63.44 to 81.74) minutes, respectively, and the mean length of stay was 4.25 (95% CI 2.02 to 6.48) and 4.04 (95% CI 1.72 to 6.36) days, respectively. Most reported complications were haemorrhage and infection with no assessable statistical difference.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Although GL seems to be a feasible approach for many general surgery interventions, the observed outcomes based on safety and efficiency are not sufficient to recommend GL as an alternative to CL or laparotomy. Larger randomised trials with a low risk of bias are warranted.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 3","pages":"171-186"},"PeriodicalIF":0.8,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1744-1633.12643","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50131657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Surgical Practice February 2023 CME for fellows 外科实践2023年2月研究员CME
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-30 DOI: 10.1111/1744-1633.12623
{"title":"Surgical Practice February 2023 CME for fellows","authors":"","doi":"10.1111/1744-1633.12623","DOIUrl":"https://doi.org/10.1111/1744-1633.12623","url":null,"abstract":"","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 2","pages":"121-122"},"PeriodicalIF":0.8,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50148336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular Surgery 2023 血管外科2023
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-30 DOI: 10.1111/1744-1633.12633
Stephen Wing Keung Cheng
We are rapidly approaching the 2-year anniversary since Vascular Surgery became a distinct speciality in surgery. Dr Chan addressed the importance of the subspeciality Vascular Nurse as an essential partner in modern vascular service. Dr Pang reviewed his 3-year results of advanced endovascular interventions for high-grade Trans-Atlantic Inter-Society Consensus-Class D (TASC-D) femoropopliteal inventions, and compared patency and clinical outcomes with the traditional bypass operations. [Extracted from the article] Copyright of Surgical Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
{"title":"Vascular Surgery 2023","authors":"Stephen Wing Keung Cheng","doi":"10.1111/1744-1633.12633","DOIUrl":"https://doi.org/10.1111/1744-1633.12633","url":null,"abstract":"We are rapidly approaching the 2-year anniversary since Vascular Surgery became a distinct speciality in surgery. Dr Chan addressed the importance of the subspeciality Vascular Nurse as an essential partner in modern vascular service. Dr Pang reviewed his 3-year results of advanced endovascular interventions for high-grade Trans-Atlantic Inter-Society Consensus-Class D (TASC-D) femoropopliteal inventions, and compared patency and clinical outcomes with the traditional bypass operations. [Extracted from the article] Copyright of Surgical Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 2","pages":"65"},"PeriodicalIF":0.8,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50148406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality incident management 质量事件管理
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-30 DOI: 10.1111/1744-1633.12634
Paul B. S. Lai
Please be reassured that I am not going to comment on the recent court case of gross negligent manslaughter in Hong Kong. But because we are moving into the ‘new normal’ after the COVID-19 (coronavirus disease 2019) pandemic, I think we should better equip ourselves in our capability and skills to handle incidents. This is a pragmatic approach because the painful reality is that incidents would not disappear from our practice. Healthcare (and surgical care in particular) is becoming increasingly complex. No matter how hard we try, somehow certain untoward events or incidents may happen to our patients. One good way to gain new insights into the management of clinical incidents would be to revise what have we learnt in the past. And let us look back into the 60s...
{"title":"Quality incident management","authors":"Paul B. S. Lai","doi":"10.1111/1744-1633.12634","DOIUrl":"https://doi.org/10.1111/1744-1633.12634","url":null,"abstract":"Please be reassured that I am not going to comment on the recent court case of gross negligent manslaughter in Hong Kong. But because we are moving into the ‘new normal’ after the COVID-19 (coronavirus disease 2019) pandemic, I think we should better equip ourselves in our capability and skills to handle incidents. This is a pragmatic approach because the painful reality is that incidents would not disappear from our practice. Healthcare (and surgical care in particular) is becoming increasingly complex. No matter how hard we try, somehow certain untoward events or incidents may happen to our patients. One good way to gain new insights into the management of clinical incidents would be to revise what have we learnt in the past. And let us look back into the 60s...","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 2","pages":"63-64"},"PeriodicalIF":0.8,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50148407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Practice May 2023 CME for Fellows 外科实践2023年5月研究员CME
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-30 DOI: 10.1111/1744-1633.12632
3. Concerning post-operative pulmonary embolism A. It has a low mortality rate. ☐ ☐ B. It is a relatively uncommon post-operative complication. ☐ ☐ C. The diagnosis of post-operative pulmonary embolism might be underestimated. ☐ ☐ D. Patients with post-operative pulmonary embolism might be asymptomatic. ☐ ☐ E. Over-treating pulmonary embolism in asymptomatic patients might lead to adverse health consequences including increasing bleeding risk after anticoagulation ☐ ☐
{"title":"Surgical Practice May 2023 CME for Fellows","authors":"","doi":"10.1111/1744-1633.12632","DOIUrl":"https://doi.org/10.1111/1744-1633.12632","url":null,"abstract":"3. Concerning post-operative pulmonary embolism A. It has a low mortality rate. ☐ ☐ B. It is a relatively uncommon post-operative complication. ☐ ☐ C. The diagnosis of post-operative pulmonary embolism might be underestimated. ☐ ☐ D. Patients with post-operative pulmonary embolism might be asymptomatic. ☐ ☐ E. Over-treating pulmonary embolism in asymptomatic patients might lead to adverse health consequences including increasing bleeding risk after anticoagulation ☐ ☐","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 2","pages":"123-124"},"PeriodicalIF":0.8,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50148337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined use of the Da Vinci robot system and the LungPoint Virtual Bronchoscopic Navigation system in the management of lung cancer: First Hong Kong experience Da Vinci机器人系统和LungPoint虚拟支气管镜导航系统在癌症治疗中的联合应用:香港首次经验
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-24 DOI: 10.1111/1744-1633.12642
Ho Chun Frederick Lau, Ming Fai Lin, Ki Kwong Li, Hoi Ming Herman Chan, Wing Shun Ng

Small ground-glass opacity intrapulmonary lesions without preoperative histological diagnosis are difficult to localise in minimal invasive thoracic surgery, especially in robotic-assisted surgery which has limited haptic feedback. Here we present two cases of using the LungPoint Virtual Bronchoscopic Navigation system for indocyanine green injection to assist with localization during robotic thoracic surgery, which might be a safe and feasible technique for such cases with impalpable lesions with no prior histological proof.

在微创胸部手术中,特别是在触觉反馈有限的机器人辅助手术中,没有术前组织学诊断的肺部小磨玻璃样混浊病变很难定位。在这里,我们介绍了两个使用LungPoint虚拟支气管镜导航系统进行吲哚青绿注射的案例,以帮助机器人胸部手术中的定位,这可能是一种安全可行的技术,适用于之前没有组织学证据的无法触及病变的案例。
{"title":"Combined use of the Da Vinci robot system and the LungPoint Virtual Bronchoscopic Navigation system in the management of lung cancer: First Hong Kong experience","authors":"Ho Chun Frederick Lau,&nbsp;Ming Fai Lin,&nbsp;Ki Kwong Li,&nbsp;Hoi Ming Herman Chan,&nbsp;Wing Shun Ng","doi":"10.1111/1744-1633.12642","DOIUrl":"https://doi.org/10.1111/1744-1633.12642","url":null,"abstract":"<p>Small ground-glass opacity intrapulmonary lesions without preoperative histological diagnosis are difficult to localise in minimal invasive thoracic surgery, especially in robotic-assisted surgery which has limited haptic feedback. Here we present two cases of using the LungPoint Virtual Bronchoscopic Navigation system for indocyanine green injection to assist with localization during robotic thoracic surgery, which might be a safe and feasible technique for such cases with impalpable lesions with no prior histological proof.</p>","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 3","pages":"187-189"},"PeriodicalIF":0.8,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50119348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of an abdominal binder on the development of incisional hernia in the long term: A prospective cohort study 腹部粘合剂对切口疝长期发展的影响:一项前瞻性队列研究
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-21 DOI: 10.1111/1744-1633.12640
Emine Arici Parlak RN, PhD, Emine Iyigun RN, PhD, Sevinc Tastan RN, PhD, Mehmet Fatih Can MD

Objectives

The effects of using an abdominal binder after abdominal surgery on the development of incisional hernias in the long term are far from certain. This study aims to analyse the effects of abdominal binder use on the development of incisional hernia in the long term.

Methods

The population of this prospective cohort study included 84 patients, who underwent abdominal surgery and were evaluated for the effects of abdominal binder use between September 2013 and April 2014. The study sample comprised 57 patients (30 used an abdominal binder and 27 did not use one), who took part in the first research and agreed to participate. We conducted a telephone survey with the participants in September 2017 and asked them to answer the questions on the symptoms of and the risk factors associated with incisional hernia.

Results

Comparison of the two groups in terms of patient, surgical and treatment characteristics revealed no statistically significant difference (P > .05). Incisional hernia occurred in eight patients who used an abdominal binder and in five patients who did not use one. There was no statistically significant relationship between abdominal binder use and the development of incisional hernia 3 years after the abdominal surgery (P > .05).

Conclusions

This study found that abdominal binder use after abdominal surgery had no effects on the development of incisional hernia in the long term. Data on abdominal binder use were self-reported by the patients. Better designed cohort studies on larger populations may be conducted in the future.

目的腹部手术后使用腹部固定器对切口疝的长期发展影响尚不确定。本研究旨在分析长期使用腹部粘合剂对切口疝发展的影响。方法本前瞻性队列研究的人群包括84名患者,他们在2013年9月至2014年4月期间接受了腹部手术,并评估了使用腹部粘合剂的效果。研究样本包括57名患者(30名使用腹部粘合剂,27名未使用),他们参加了第一项研究并同意参与。2017年9月,我们对参与者进行了电话调查,并要求他们回答有关切口疝症状和相关风险因素的问题。结果两组患者、手术及治疗特点比较,差异无统计学意义(P >; .05)。使用腹部固定器的8名患者和未使用固定器的5名患者发生切口疝。腹部粘合剂的使用与切口疝的发展之间没有统计学上的显著关系3 腹部手术后数年(P >; .05)。结论本研究发现,从长远来看,腹部手术后使用腹部粘合剂对切口疝的发展没有影响。使用腹部粘合剂的数据由患者自我报告。未来可能会对更大的人群进行设计更好的队列研究。
{"title":"Effects of an abdominal binder on the development of incisional hernia in the long term: A prospective cohort study","authors":"Emine Arici Parlak RN, PhD,&nbsp;Emine Iyigun RN, PhD,&nbsp;Sevinc Tastan RN, PhD,&nbsp;Mehmet Fatih Can MD","doi":"10.1111/1744-1633.12640","DOIUrl":"https://doi.org/10.1111/1744-1633.12640","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The effects of using an abdominal binder after abdominal surgery on the development of incisional hernias in the long term are far from certain. This study aims to analyse the effects of abdominal binder use on the development of incisional hernia in the long term.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The population of this prospective cohort study included 84 patients, who underwent abdominal surgery and were evaluated for the effects of abdominal binder use between September 2013 and April 2014. The study sample comprised 57 patients (30 used an abdominal binder and 27 did not use one), who took part in the first research and agreed to participate. We conducted a telephone survey with the participants in September 2017 and asked them to answer the questions on the symptoms of and the risk factors associated with incisional hernia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Comparison of the two groups in terms of patient, surgical and treatment characteristics revealed no statistically significant difference (<i>P</i> &gt; .05). Incisional hernia occurred in eight patients who used an abdominal binder and in five patients who did not use one. There was no statistically significant relationship between abdominal binder use and the development of incisional hernia 3 years after the abdominal surgery (<i>P</i> &gt; .05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study found that abdominal binder use after abdominal surgery had no effects on the development of incisional hernia in the long term. Data on abdominal binder use were self-reported by the patients. Better designed cohort studies on larger populations may be conducted in the future.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 3","pages":"138-147"},"PeriodicalIF":0.8,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50140275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Segment 3 cholangiojejunostomy for unresectable peri-hilar cholangiocarcinoma: A case report and literature review 胆管-空肠吻合术治疗不可切除的肝门周围胆管癌1例报告及文献复习
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-21 DOI: 10.1111/1744-1633.12641
Anisse Tidjane, Nabil Boudjenan, Nacim Ikhlef, Aicha Bengueddach, Sif-Elislem Meharzi, Hakim Larbi, Anissa Ourabah, Benali Tabeti

Surgical management of unresectable perihilar cholangiocarcinoma is no longer relevant. Often these patients benefit from less invasive endoscopic or radiological management, but in the event of failure of these techniques, and in selected patients, cholangiojejunostomy in segment 3 can be an effective option. We describe the case of a 48-year-old patient presenting with an unresectable perihilar cholangiocarcinoma, in whom palliative endoscopic management failed two times and an open segment 3 intrahepatic cholangiojejunostomy was performed. The patient was discharged on the 7th day, has a complete resolution of jaundice at 2 months and is alive at 6 months without any readmission.

手术治疗不可切除的肝门周围胆管癌已不再相关。通常这些患者受益于微创内镜或放射治疗,但在这些技术失败的情况下,在选定的患者中,第3段胆管空肠吻合术是一种有效的选择。我们描述的情况下,48岁的病人提出了一个不可切除的肝门周围胆管癌,其中姑息性内镜管理失败两次,并进行了开放段3肝内胆管空肠吻合术。患者于第7天出院,2个月时黄疸完全消退,6个月时存活,无再入院。
{"title":"Segment 3 cholangiojejunostomy for unresectable peri-hilar cholangiocarcinoma: A case report and literature review","authors":"Anisse Tidjane,&nbsp;Nabil Boudjenan,&nbsp;Nacim Ikhlef,&nbsp;Aicha Bengueddach,&nbsp;Sif-Elislem Meharzi,&nbsp;Hakim Larbi,&nbsp;Anissa Ourabah,&nbsp;Benali Tabeti","doi":"10.1111/1744-1633.12641","DOIUrl":"10.1111/1744-1633.12641","url":null,"abstract":"<p>Surgical management of unresectable perihilar cholangiocarcinoma is no longer relevant. Often these patients benefit from less invasive endoscopic or radiological management, but in the event of failure of these techniques, and in selected patients, cholangiojejunostomy in segment 3 can be an effective option. We describe the case of a 48-year-old patient presenting with an unresectable perihilar cholangiocarcinoma, in whom palliative endoscopic management failed two times and an open segment 3 intrahepatic cholangiojejunostomy was performed. The patient was discharged on the 7th day, has a complete resolution of jaundice at 2 months and is alive at 6 months without any readmission.</p>","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 4","pages":"239-243"},"PeriodicalIF":0.8,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72374967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enoxaparin initiation after chronic subdural haematoma evacuation: a randomized clinical trial on timing and outcomes 慢性硬膜下血肿清除后开始使用依诺肝素:一项关于时间和结果的随机临床试验
IF 0.8 4区 医学 Q4 SURGERY Pub Date : 2023-05-21 DOI: 10.1111/1744-1633.12639
Mehdi Shafiei, Masih Sabouri, Bahram Aminmansour, Mehdi Mahmoodkhani, Arman Sourani, Iman Salehi, Mina Foroughi

Aim

Patients with chronic subdural haematoma (CSDH) are at a significant risk for venous thromboembolism (VTE). Surgeons should weigh the advantages versus disadvantages of anticoagulants in the postoperative period.

Patients and Methods

This study was a randomized clinical trial conducted in Isfahan, Iran, from May 2016 to April 2021. Patients with CSDH eligible for bur-hole craniostomy were primarily enrolled. All of them underwent bilateral lower limb Doppler ultrasonography (DUS) for deep venous thrombosis (DVT) screening. The patients were randomized into the case (n = 66, enoxaparin initiation 24 h after operation) and control (n = 70, enoxaparin initiation 72 h after operation) groups. Routine postoperative brain computed tomography scans were obtained 1 and 3 days after surgery. A second DUS was performed 96 h after operation to screen newly developed venous thrombosis; P value <.05 was defined significant.

Results

A total of 73 patients (59.8%) were female and 49 (40.2%) were male. The mean age was 65.1 ± 10.19 years; 9.9% of the patients had previously used antiplatelets. One patient had asymptomatic preoperative DVT. The mean values for enoxaparin dosage were 40.4918 ± 5.43 mg/day. Postoperative DVT or rebleeding prevalence was 0% in both groups. The mean follow-up duration was 19.139 ± 2.2 months. Long-term recurrence rate was 2.4% (n = 3). Postoperative pneumocephalus was associated with a higher recurrence rate (P = .031).

Conclusion

In terms of VTE chemoprophylaxis, following bur-hole craniostomy for CSDH, enoxaparin will effectively prevent VTE development without any clinically significant rebleeding.

目的慢性硬膜下血肿(CSDH)患者发生静脉血栓栓塞(VTE)的风险很大。外科医生应在术后权衡抗凝血剂的优缺点。患者和方法本研究是一项随机临床试验,于2016年5月至2021年4月在伊朗伊斯法罕进行。符合钻孔开颅术条件的CSDH患者主要入选。所有患者均接受了双侧下肢多普勒超声(DUS)检查,以筛查深静脉血栓形成(DVT)。患者被随机分为病例(n = 66,依诺肝素启动24 h)和控制(n = 70,依诺肝素启动72 术后h)组。常规的术后脑部计算机断层扫描分别为1和3 手术后几天。进行了第二次DUS 96 术后h筛查新发静脉血栓形成;P值<;。05被定义为显著。结果女性73例(59.8%),男性49例(40.2%)。平均年龄65.1岁 ± 10.19 年;9.9%的患者以前使用过抗血小板药物。一名患者术前无症状DVT。依诺肝素剂量的平均值为40.4918 ± 5.43毫克/天。两组术后DVT或再出血的发生率均为0%。平均随访时间为19.139 ± 2.2 月。长期复发率为2.4%(n = 3) 。术后肺脑出血的复发率较高(P = .031)。结论就VTE的化学预防而言,在CSDH的钻孔开颅术后,依诺肝素将有效地预防VTE的发展,而没有任何临床意义的再出血。
{"title":"Enoxaparin initiation after chronic subdural haematoma evacuation: a randomized clinical trial on timing and outcomes","authors":"Mehdi Shafiei,&nbsp;Masih Sabouri,&nbsp;Bahram Aminmansour,&nbsp;Mehdi Mahmoodkhani,&nbsp;Arman Sourani,&nbsp;Iman Salehi,&nbsp;Mina Foroughi","doi":"10.1111/1744-1633.12639","DOIUrl":"https://doi.org/10.1111/1744-1633.12639","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Patients with chronic subdural haematoma (CSDH) are at a significant risk for venous thromboembolism (VTE). Surgeons should weigh the advantages versus disadvantages of anticoagulants in the postoperative period.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients and Methods</h3>\u0000 \u0000 <p>This study was a randomized clinical trial conducted in Isfahan, Iran, from May 2016 to April 2021. Patients with CSDH eligible for bur-hole craniostomy were primarily enrolled. All of them underwent bilateral lower limb Doppler ultrasonography (DUS) for deep venous thrombosis (DVT) screening. The patients were randomized into the case (<i>n</i> = 66, enoxaparin initiation 24 h after operation) and control (<i>n</i> = 70, enoxaparin initiation 72 h after operation) groups. Routine postoperative brain computed tomography scans were obtained 1 and 3 days after surgery. A second DUS was performed 96 h after operation to screen newly developed venous thrombosis; <i>P</i> value &lt;.05 was defined significant.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 73 patients (59.8%) were female and 49 (40.2%) were male. The mean age was 65.1 ± 10.19 years; 9.9% of the patients had previously used antiplatelets. One patient had asymptomatic preoperative DVT. The mean values for enoxaparin dosage were 40.4918 ± 5.43 mg/day. Postoperative DVT or rebleeding prevalence was 0% in both groups. The mean follow-up duration was 19.139 ± 2.2 months. Long-term recurrence rate was 2.4% (<i>n</i> = 3). Postoperative pneumocephalus was associated with a higher recurrence rate (<i>P</i> = .031).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In terms of VTE chemoprophylaxis, following bur-hole craniostomy for CSDH, enoxaparin will effectively prevent VTE development without any clinically significant rebleeding.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51190,"journal":{"name":"Surgical Practice","volume":"27 3","pages":"153-162"},"PeriodicalIF":0.8,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50140274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgical Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1